---
provider: openai
model: o3-deep-research-2025-06-26
cached: false
start_time: '2025-12-27T16:34:12.905612'
end_time: '2025-12-27T16:43:09.181790'
duration_seconds: 536.28
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: KCTD12
  gene_symbol: KCTD12
  uniprot_accession: Q96CX2
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD12; AltName:
    Full=Pfetin; AltName: Full=Predominantly fetal expressed T1 domain;'
  gene_info: Name=KCTD12; Synonyms=C13orf2, KIAA1778, PFET1;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: BTB/POZ_dom. (IPR000210); H1_KCTD12. (IPR049905); SKP1/BTB/POZ_sf.
    (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
    top_p: 1.0
citation_count: 128
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q96CX2
- **Protein Description:** RecName: Full=BTB/POZ domain-containing protein KCTD12; AltName: Full=Pfetin; AltName: Full=Predominantly fetal expressed T1 domain;
- **Gene Information:** Name=KCTD12; Synonyms=C13orf2, KIAA1778, PFET1;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** BTB/POZ_dom. (IPR000210); H1_KCTD12. (IPR049905); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "KCTD12" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'KCTD12' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **KCTD12** (gene ID: KCTD12, UniProt: Q96CX2) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

# KCTD12 (BTB/POZ Domain-Containing Protein KCTD12) – Functional Annotation and Recent Insights

## Gene Identity and Structure  
**KCTD12** is a human gene (Homo sapiens) encoding the BTB/POZ domain-containing protein KCTD12, also known as *Pfetin* (Predominantly Fetal Expressed T1 domain protein) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin)). The gene is located on chromosome 13 (13q22.3) and was originally identified as *C13orf2/KIAA1778* in genomic surveys. KCTD12 belongs to the **KCTD family** (Potassium Channel Tetramerization Domain-containing proteins), a group of 25 proteins characterized by a conserved N-terminal **BTB/POZ domain** ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=The%20KCTD%20family%20arose%20from,15)). The BTB/POZ domain (≈95 amino acids) mediates **protein–protein interactions and oligomerization** ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=evolutive%20divergence%20and%20share%20a,15)). Indeed, KCTD12 self-assembles into a homotetramer via this BTB domain ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L268%20The%20circular,proteins%20assumed%20a%20tetrameric%20organization)), similar to the tetramerization domain of voltage-gated K⁺ channels (hence the family name). KCTD12’s C-terminal region (sometimes called the “H1 domain”) is a unique segment that confers its specific interactions and functions ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=a%2C%20Ribbon%20representation%20of%20the,H1%7D%20subunits%20%28green%20and%20cyan)). Notably, KCTD12 lacks any transmembrane region and is predominantly a **cytosolic protein**. It tends to localize to the cytosolic face of cellular membranes by binding to membrane-bound partners, as described below. This gene is **expressed highly in the nervous system**, especially in the brain ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=pfetin%2C%20C13orf2%2C%20and%20PFET1%2C%20is,levels%20in%20the%20brain%20and)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94)), and was first noted for its strong expression in fetal tissues (hence the name Pfetin) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin)). In adult tissues, KCTD12 expression is largely neuronal; outside the brain it is low or absent under normal conditions ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=pfetin%2C%20C13orf2%2C%20and%20PFET1%2C%20is,levels%20in%20the%20brain%20and)).

**Verification of Identity:** The KCTD12 described here corresponds to UniProt accession **Q96CX2**, a human protein with a BTB/POZ domain, and **not** to any unrelated gene. The protein’s synonyms (Pfetin, C13orf2, PFET1) and domain composition match the UniProt record, ensuring we are focusing on the correct gene product. KCTD12 should not be confused with similarly named genes in other species or with other KCTD family members. All information below refers to human KCTD12 as identified above.

## Role as an Auxiliary Subunit of GABA<sub>B</sub> Receptors (Neuronal Function)  
KCTD12 is best known for its **role in the nervous system as an auxiliary subunit of the GABA<sub>B</sub> receptor**, a G-protein-coupled receptor (GPCR) for the neurotransmitter γ-aminobutyric acid (GABA). In 2010, native GABA<sub>B</sub> receptors were discovered to form heteromultimeric complexes with KCTD family proteins, including KCTD12 ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=12,View%20Article)). KCTD12, along with its paralogs KCTD8 and KCTD16, comprises the *“Clade F”* of KCTDs dedicated to GABA<sub>B</sub> modulation ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94)). These cytosolic proteins attach to the C-terminal intracellular domain of the GABA<sub>B2</sub> subunit, becoming integral components of the receptor complex ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=proteins%20,pronounced%20desensitization%20of%20the%20K)). **KCTD12 association does not alter receptor assembly or trafficking to the surface**, as KCTD12 binds the receptor already in the endoplasmic reticulum without impeding normal maturation ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=GABA,thereby%20increases%20the%20magnitude%20of)). In fact, KCTD12 remains bound to GABA<sub>B</sub> receptors at the cell surface and during endocytosis ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=receptors%20associate%20with%20KCTD12%20while,B)). This stable association has important functional consequences for GABA<sub>B</sub> signaling.

**Upregulation of Receptor Signaling:** KCTD12 *increases* the availability and efficacy of GABA<sub>B</sub> receptors on the neuronal surface. Experiments in heterologous cells and neurons show that assembling KCTD12 with GABA<sub>B</sub> receptors in the ER leads to reduced constitutive receptor internalization ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=influence%20maturation%20of%20the%20receptor,receptors%20at%20the%20neuronal%20plasma)). In other words, KCTD12 acts as a retention factor, keeping more receptors at the plasma membrane. As a result, neurons with KCTD12 have a higher magnitude of GABA<sub>B>-mediated currents. Notably, knocking out or silencing Kctd12 in mouse hippocampal neurons significantly **reduces the GABA<sub>B</sub>-activated K⁺ current** (mediated by G-protein gated inward rectifier K⁺ channels), indicating that KCTD12 normally enhances the functional coupling of receptors to ion channel signaling ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=remains%20associated%20with%20the%20receptor,of%20the%20auxiliary%20subunit%20KCTD12)). Consistently, a 2013 biochemical study demonstrated that KCTD12 *up-regulates* GABA<sub>B</sub> receptor signaling by increasing receptor density at the membrane and stabilizing receptor–G protein interactions ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=constitutive%20receptor%20internalization%20and%20thereby,of%20the%20auxiliary%20subunit%20KCTD12)).

**Effects on Pharmacology and Kinetics:** Beyond boosting signal amplitude, KCTD12 profoundly shapes the *kinetic profile* and pharmacological properties of GABA<sub>B</sub> receptor responses. KCTD12-bound receptors exhibit altered agonist potency and **faster onset and desensitization** of inhibitory currents compared to receptors without KCTD subunits ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=distribution%20to%20axons%20and%20dendrites,association%20with%20KCTD12%20does%20not)) ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=pfetin%2C%20C13orf2%2C%20and%20PFET1%2C%20is,levels%20in%20the%20brain%20and)). In electrophysiological recordings, the presence of KCTD12 causes the GABA<sub>B>-activated K⁺ current to **desensitize rapidly** and more profoundly during sustained agonist exposure ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=proteins%20,pronounced%20desensitization%20of%20the%20K)). Mechanistically, KCTD12’s C-terminal “H1” domain directly interacts with the G-protein βγ subunits released upon receptor activation ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=G%CE%B1_,stain)) ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor)). Structural studies (Nature, 2019) revealed that the H1 domain of KCTD12 binds Gβγ at a specific interface, sequestering the Gβγ complex away from its effector (the potassium channel) ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor)) ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2)). This **creates a brake on GABA<sub>B> signaling, producing rapid desensitization** of the inhibitory downstream effect (the K⁺ current) ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=proteins%20,pronounced%20desensitization%20of%20the%20K)). A critical motif (NFLEQ) in KCTD12’s H1 domain is required for this desensitizing effect ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=a%2C%20Ribbon%20representation%20of%20the,H1%7D%20subunits%20%28green%20and%20cyan)), highlighting how a specific sequence in KCTD12 modulates receptor signaling kinetics. Furthermore, KCTD12 was shown to influence agonist pharmacodynamics: for instance, incorporation of KCTD12 can shift the EC<sub>50</sub> for GABA, effectively **altering the receptor’s sensitivity to neurotransmitter** ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=distribution%20to%20axons%20and%20dendrites,association%20with%20KCTD12%20does%20not)). In summary, **KCTD12 acts as a modulatory subunit** that fine-tunes GABA<sub>B</sub> receptor function, **increasing the magnitude of signaling while accelerating its kinetics**. This dual action shapes synaptic inhibition in the brain, ensuring a strong but transient response to GABA.

**Biological Significance in the Brain:** The GABA<sub>B</sub> receptor is a principal mediator of slow inhibitory synaptic transmission in the central nervous system. By associating with these receptors, KCTD12 plays a role in regulating neuronal excitability, synaptic plasticity, and behavior. Variations in KCTD12 function have been linked to neurological and psychiatric phenomena. For example, genetic studies have implicated **KCTD12 variants in mood and cognitive disorders**. A genome-wide association analysis in 2019 found KCTD12 to be significantly associated with the trait of **rumination**, a risk factor for depression ([www.nature.com](https://www.nature.com/articles/s41398-019-0454-1#:~:text=hit%20emerged%20at%20the%20SNP,transdiagnostic%20nature%20of%20rumination%2C%20and)). Other research has noted KCTD12 as a candidate gene in bipolar disorder and schizophrenia cohorts ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=of%20KCTD12%3A%20insights%20into%20interaction,26%2C%20488%E2%80%93495%20%282013)). In mouse models, Kctd12 expression in the hippocampus was induced by chronic stress, and experimentally **elevating Kctd12 made mice more vulnerable to depressive-like behaviors**, whereas Kctd12 knockdown had a resilience effect ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=to%20investigate%20behavioral%20responses%20to,suppressing%20the%20excess%20expression%20of)) ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=increased%20the%20expression%20of%20Kctd12,suppressing%20the%20excess%20expression%20of)). These findings suggest that KCTD12’s regulation of GABA<sub>B</sub> signaling can impact stress responses and mood, aligning with the protein’s role in inhibitory neurotransmission. It is being explored as a potential therapeutic target in stress-related mood disorders ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=The%20effects%20of%20Kctd12%2C%20an,mood%20disorders%20like%20depression%20treatment)). Overall, in the nervous system KCTD12 functions as an **adapter protein in a key inhibitory pathway**, helping to maintain the balance of neural activity through its modulation of GABA<sub>B</sub> receptors.

## Mechanistic Properties and Interactions  
**Structural Assembly:** KCTD12’s BTB domain mediates both homo-oligomerization and interaction with partner proteins. As noted, KCTD12 assembles into a **tetramer** (dimer-of-dimers) via the BTB domain ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L268%20The%20circular,proteins%20assumed%20a%20tetrameric%20organization)). This tetramer is the functional unit that attaches to a GABA<sub>B</sub> receptor: biochemical pull-downs have shown one KCTD12 tetramer can bind the dimeric GABA<sub>B1</sub>-GABA<sub>B2</sub> receptor complex ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2)). The BTB domain of KCTD12 specifically binds to a segment of the GABA<sub>B2</sub> intracellular tail, tethering the KCTD12 tetramer to the receptor ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=a%2C%20KCTD16_,down%20with%20glutathione%E2%80%93sepharose%20beads.%20Glutathione)). Meanwhile, the flexible C-terminal region of KCTD12 reaches to interact with G-proteins as described. This multivalent bridging role is unique for KCTD12’s clade. It’s worth noting that many BTB-domain proteins serve as adapters for Cullin3-based ubiquitin ligase complexes (CRL3). However, **KCTD12 does not seem to function in ubiquitin-mediated proteolysis**. Biophysical studies have found that the isolated BTB domain of KCTD12 *fails to bind* the Cullin3 scaffold, in contrast to certain other KCTDs ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do)) ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=heat%20exchanges%20upon%20titration%20of,This)). Isothermal titration calorimetry and gel filtration assays showed **no stable interaction between KCTD12’s BTB domain and Cullin3**, whereas BTBs from KCTD11 or KCTD6 (related family members) form robust Cul3 complexes ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do)) ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=https%3A%2F%2Fdoi)). This indicates that **KCTD12’s functions are “Cullin-independent”**, aligning with its role in receptor signaling rather than serving as an E3 ubiquitin ligase adapter. Instead of targeting proteins for degradation, KCTD12’s BTB/POZ domain primarily mediates assembly with the GABA<sub>B</sub> receptor complex and possibly other protein partners in non-neuronal contexts.

**Signaling Pathways:** Through its protein–protein interactions, KCTD12 can influence several cellular signaling pathways. In neurons, the key pathway is **G<sub>i/o</sub>-protein signaling** downstream of GABA<sub>B</sub>. By binding Gβγ, KCTD12 effectively regulates the **Gβγ–effector pathway** (which includes activation of inward-rectifier K⁺ channels and inhibition of adenylyl cyclase). This has ripple effects on **ion channel activity and second-messenger (cAMP) levels** in neurons ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC5508304/#:~:text=Introduction%20GABA_,GIRK%2C%20also)). Importantly, sequestration of Gβγ by KCTD12 also means less Gβγ is available to activate intracellular enzymes like **PI3K**. In fact, **KCTD12 has been noted to dampen PI3K–AKT signaling** in some contexts ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the)). Gβγ normally activates class I PI3K, leading to AKT phosphorylation. A 2021 review pointed out that KCTD12 can inhibit AKT pathway activation, presumably by interfering with Gβγ’s ability to stimulate PI3K ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the)). This mechanism is analogous to KCTD5 (another family member) which promotes ubiquitin-mediated turnover of Gβγ, thereby reducing AKT signaling ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the)). While KCTD12 does not ubiquitinate Gβγ, its direct binding might spatially sequester Gβγ or otherwise impede prolonged PI3K activation. Thus, through GABA<sub>B</sub> or other G-protein-coupled mechanisms, KCTD12 may exert a **braking effect on the PI3K/AKT pathway**. In support of this, loss of KCTD12 has been correlated with increased AKT activity in certain cell types. For example, in breast cancer cells, silencing KCTD12 led to enhanced AKT phosphorylation and accelerated cell cycle progression, while restoring KCTD12 curbed AKT signaling and proliferation ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L518%20KCTD12%20displays,Consistently%2C%20ectopic%20expression%20of)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of)).

Outside of neuronal signaling, emerging evidence suggests KCTD12 can interact with components of the **cell cycle regulatory machinery**. Notably, in some cancer cell contexts KCTD12 was found to bind **CDK1 (cyclin-dependent kinase 1) and CDC25B**, forming a complex that facilitates CDK1 activation and entry into mitosis ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1)). A study reported that **high KCTD12 levels can promote the G2/M cell cycle transition** by supporting the CDK1/CDC25B/Aurora A kinase axis ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1)). In these cells, KCTD12 acted unconventionally as a pro-proliferative factor: disrupting the KCTD12–CDK1 interaction using small molecules or siRNA was shown to suppress tumor cell growth ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=levels%20have%20been%20correlated%20with,a%20complex%20that%20supports%20CDK1)). This finding is intriguing because it positions KCTD12 in a completely different pathway (cell cycle control) separate from its GABA<sub>B</sub> role. It hints that KCTD12’s protein–protein interaction capacity (via the BTB domain or other regions) might allow it to serve as a scaffold or regulator in various signaling complexes depending on the cell type. However, such interactions are context-dependent and may not occur in all tissues. 

In summary, **KCTD12 is a versatile adaptor protein**. In neurons it couples a neurotransmitter receptor to ion channels and G-proteins, modulating synaptic inhibition. In other cells, it can interface with signaling pathways like **MAPK/ERK and cell-cycle kinases** (as discussed below in disease contexts). Unlike many KCTDs, it does not broadly function in ubiquitin ligation, but it can still influence protein stability indirectly by affecting signaling cascades (e.g., reducing GABA<sub>B> receptor internalization, or impacting Gβγ stability via KCTD5 partnership). The precise mechanisms of KCTD12 in non-neuronal cells remain an active area of research.

## Involvement in Biological Processes and Disease Contexts  

### KCTD12 in Cancer and Cell Proliferation  
Although KCTD12 is largely a neuronal protein, it has attracted significant interest in oncology due to its **aberrant expression in tumors** and potential role in tumor cell biology. KCTD12 was first spotlighted in cancer research under the name **Pfetin** in gastrointestinal stromal tumors. In a landmark proteomics study, *pfetin (KCTD12)* was identified as a protein strongly expressed in tumors with favorable outcomes ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097)). Subsequent analysis of patient samples revealed **pfetin as a prognostic biomarker in GIST (Gastrointestinal Stromal Tumors)** ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097)). Patients whose GIST tumors **retained KCTD12 expression had markedly better survival** than those whose tumors lost KCTD12. One study reported a 5-year recurrence-free survival of **95.6% in KCTD12-positive GISTs vs. only 16.7% in KCTD12-negative cases** (p < 0.0001) ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=solitary%20fibrous%20tumor%20%20,These%20findings%20suggest%20that)). In multivariate analysis, **KCTD12 status was an independent predictor of patient outcome**, even when accounting for other factors like proliferative index ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=recurrence,diagnosis%20and%20prognosis%20of%20GIST)). These data firmly established KCTD12 as a **useful clinical biomarker** for GIST diagnosis and prognosis ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=after%20accounting%20for%20Ki,diagnosis%20and%20prognosis%20of%20GIST)). Immunohistochemical testing for pfetin has been suggested to help identify low-risk GIST patients, as **loss of KCTD12 correlates with aggressive, high-risk disease** ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097)).

The tumor-suppressive association of KCTD12 is not limited to GIST. **Downregulation or loss of KCTD12 has been observed in multiple cancers**, often correlating with increased malignancy:  

- **Colorectal Cancer (CRC):** KCTD12 levels are significantly reduced in colorectal carcinoma tissues compared to normal colon epithelium ([www.nature.com](https://www.nature.com/articles/srep20460#:~:text=CD44%2C%20CD133%20and%20CD29%2C%20by,this%20report%20reveals%20that%20KCTD12)). Low KCTD12 in CRC is linked to tumor progression; it was found to be an *independent prognostic factor* for poorer overall and disease-free survival in patients (p = 0.007) ([www.nature.com](https://www.nature.com/articles/srep20460#:~:text=CD44%2C%20CD133%20and%20CD29%2C%20by,target%20for%20patients%20with%20CRC)). Functionally, KCTD12 appears to restrain the stem-like properties of CRC cells. A 2016 study showed that **silencing KCTD12 enhanced cancer stem cell markers and self-renewal in CRC cells**, whereas overexpressing KCTD12 suppressed these stemness traits ([www.nature.com](https://www.nature.com/articles/srep20460#:~:text=we%20demonstrated%20that%20KCTD12%2C%20potassium,decreased%20level%20of%20KCTD12%20is)). Mechanistically, KCTD12 suppresses the **ERK/MAPK pathway** in CRC cells – loss of KCTD12 led to hyperactivation of ERK1/2 and upregulation of stemness genes, while an ERK inhibitor could reverse the effects of KCTD12 knockdown ([www.nature.com](https://www.nature.com/articles/srep20460#:~:text=using%20a%20colony%20formation%20assay%2C,this%20report%20reveals%20that%20KCTD12)). This places KCTD12 as a negative regulator of the pro-proliferative ERK pathway. Consistently, KCTD12-deficient CRC xenograft tumors grew more aggressively in mice, whereas KCTD12 restoration reduced tumor growth and metastasis ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20colorectal%20cancer%20,98)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20colorectal%20cancer%20,98)). These findings suggest KCTD12 acts as a **tumor suppressor in colorectal cancer**, keeping oncogenic pathways like ERK in check and limiting the stem cell–like subpopulation of tumor cells. 

- **Breast Cancer:** Large-scale transcriptomic analyses (e.g. TCGA data mining in 2021) found that **KCTD12 expression is frequently downregulated in breast cancer** tissue compared to normal breast ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L518%20KCTD12%20displays,Consistently%2C%20ectopic%20expression%20of)). Low KCTD12 in breast tumors was associated with more aggressive clinicopathological features and worse patient survival ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L518%20KCTD12%20displays,Consistently%2C%20ectopic%20expression%20of)). Functional studies demonstrated that **knocking down KCTD12 in breast cancer cell lines accelerates proliferation and drives cells from G1 into S phase** ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of)). This was linked to **hyperactivation of the AKT pathway** when KCTD12 is absent: AKT phosphorylation increased, leading to downstream effects on cell cycle regulators (such as FOXO1) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of)). Conversely, reintroducing or overexpressing KCTD12 in these cells dampened AKT signaling and slowed cell cycle progression ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of)). Therefore, in breast cancer KCTD12 seems to inhibit growth by modulating PI3K–AKT signaling and cell cycle checkpoints. Clinically, one 2021 study identified KCTD12 as a **potential prognostic marker in breast cancer**, noting that higher KCTD12 correlates with better survival and possibly a more robust anti-tumor immune response ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8798602/#:~:text=Ribonucleic%20acid,and%20the%20Gene%20Expression%20Profiling)) ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8798602/#:~:text=Background)). Gene set enrichment hinted that KCTD12 might influence the tumor microenvironment and immune cell infiltration in breast tumors ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8798602/#:~:text=Ribonucleic%20acid,and%20the%20Gene%20Expression%20Profiling)), although the exact mechanisms are still being unraveled.

- **Melanoma:** KCTD12 has also been reported to act as a tumor suppressor in melanoma. Metastatic melanoma cell lines showed **lower KCTD12 levels** compared to their primary tumor counterparts ([tcr.amegroups.org](https://tcr.amegroups.org/article/view/48228/html#:~:text=,Biomarker%20of%20Gastrointestinal%20Stromal%20Tumors)). Experimental downregulation of KCTD12 in melanoma was found to increase the expression of stemness markers and enhance the aggressive behavior of melanoma cells ([tcr.amegroups.org](https://tcr.amegroups.org/article/view/48228/html#:~:text=,Biomarker%20of%20Gastrointestinal%20Stromal%20Tumors)). Conversely, **enforcing KCTD12 expression in melanoma cells induces cell cycle arrest in G2/M, slows proliferation, and promotes apoptosis** ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L522%20KCTD12%20in,ESCC)). In an *in vivo* melanoma xenograft model, tumors with high KCTD12 grew more slowly, supporting its growth-inhibitory role ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L522%20KCTD12%20in,ESCC)). These effects in melanoma were tied to KCTD12’s interference with cell cycle regulators, echoing the pattern seen in other cancers.

- **Esophageal Squamous Cell Carcinoma (ESCC):** Similarly, KCTD12 appears to function as a tumor suppressor in ESCC. A 2018 study noted that **KCTD12 is frequently silenced in ESCC tumors**, and its loss correlates with advanced disease ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20in%20human%20uveal%20melanoma,ESCC)). Restoration of KCTD12 in ESCC cell lines inhibited their growth, suggesting therapeutic potential ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20in%20human%20uveal%20melanoma,ESCC)).

Intriguingly, **not all cancers follow the same pattern**. There are reports where **KCTD12 is **upregulated** and may contribute to oncogenesis** in certain contexts:  

- In **cervical carcinoma, lung adenocarcinoma, and a subset of colon cancers**, tumor samples have shown **higher-than-normal KCTD12 expression**, and this was paradoxically associated with **poorer patient prognosis** ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=levels%20have%20been%20correlated%20with,a%20complex%20that%20supports%20CDK1)). In these cases, KCTD12 might be co-opted by cancer cells to drive proliferation. The mechanism proposed involves the **KCTD12–CDK1 interaction** mentioned earlier: high KCTD12 can bind and support CDK1/cyclin activity, thus promoting the G2/M transition and rapid cell division ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1)). For example, an Oncogene study in 2017 demonstrated that **KCTD12 binds the mitotic kinase CDC25B and stabilizes the CDC25B–CDK1–Aurora A complex**, facilitating mitotic entry and tumor growth ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1)). Inhibiting KCTD12 (genetically or with drugs) in those cancer cells disrupted this complex and suppressed tumor cell proliferation ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=levels%20have%20been%20correlated%20with,a%20complex%20that%20supports%20CDK1)). Therefore, in some malignancies KCTD12 may act as a context-dependent oncogene, especially when its interplay with cell cycle regulators becomes advantageous to the tumor. It is possible that the **role of KCTD12 in cancer is cell-type specific**, influenced by which signaling pathways are dominant in that cancer. The *dual nature* of KCTD12 – tumor-suppressive in some settings and tumor-promoting in others – underscores the complexity of cancer biology. It may reflect different interaction partners or post-translational modifications of KCTD12 in different cellular environments ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin)). Current research is investigating what factors dictate these opposite roles.

### Current Applications and Clinical Relevance  
Given these findings, KCTD12 is being explored in several practical contexts:  

- **Biomarker Development:** KCTD12/Pfetin is already used as a **biomarker in GIST pathology**. Some clinical centers have incorporated pfetin immunohistochemistry to help stratify GIST patients by risk of recurrence ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097)). Its remarkable prognostic power (nearly 80% difference in 5-year recurrence-free survival based on expression) makes it a valuable adjunct to traditional risk factors ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=solitary%20fibrous%20tumor%20%20,These%20findings%20suggest%20that)). Researchers have suggested using KCTD12 in combination with markers like Ki-67 to improve GIST outcome predictions ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=recurrence,diagnosis%20and%20prognosis%20of%20GIST)). Additionally, **pan-cancer analyses** in 2023 have highlighted KCTD12 as a potential diagnostic marker across multiple tumor types ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=Abnormal%20expression%20of%20the%20potassium,genomic%20heterogeneity%2C%20and%20diagnostic%20specificity)) ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=levels%20decreased%20in%20most%20tumors,KCTD12%20showed%20high)). In a comprehensive study of >30 cancers (using TCGA data), **KCTD12 levels were found to be significantly different in tumors vs. normal tissue for several cancers** ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=using%20The%20Cancer%20Genome%20Atlas,of%20KCTD12%20decreased%20in%20several)). For example, KCTD12 mRNA/protein was generally *down* in malignancies such as colorectal, uterine, and head/neck cancers (consistent with tumor-suppressor behavior), while *elevated* in a few others like pancreatic adenocarcinoma and glioblastoma ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=levels%20decreased%20in%20most%20tumors,KCTD12%20showed%20high)). That study also showed KCTD12 expression had high diagnostic sensitivity for certain cancers and correlated with features like tumor mutational burden and immune infiltration ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=tumors%2C%20such%20as%20S200%20and,stemness%2C%20tumor%20burden%2C%20and%20other)). Such findings pave the way for using KCTD12 as part of multi-gene panels for cancer diagnosis or prognostication.

- **Therapeutic Target Research:** KCTD12’s role in GABA<sub>B</sub> signaling makes it a potential **target in neurological disorders**. While no drugs currently target KCTD12 directly, understanding its modulation of GABA<sub>B</sub> could inform treatments for epilepsy, pain, or depression (where GABA<sub>B</sub> receptors are relevant). For instance, if KCTD12 upregulation contributes to stress susceptibility ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=increased%20the%20expression%20of%20Kctd12,suppressing%20the%20excess%20expression%20of)) ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=acute%20stress%20and%20increased%20vulnerability,suppressing%20the%20excess%20expression%20of)), then disrupting KCTD12–GABA<sub>B</sub> interactions might have antidepressant or anxiolytic effects. Conversely, enhancing KCTD12 function could potentially strengthen inhibitory signaling in conditions of hyperexcitability. These ideas are still speculative, but *KCTD12-knockout mice and other models are being studied to evaluate behavioral and cognitive impacts* ([www.sciencedirect.com](https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=to%20investigate%20behavioral%20responses%20to,suppressing%20the%20excess%20expression%20of)). In oncology, KCTD12 is not yet a direct drug target, but its involvement in pathways like ERK, AKT, and cell cycle makes it an attractive **node for intervention**. For tumors where KCTD12 is lost, strategies to boost its expression or mimic its effect (e.g. dampening ERK/AKT signaling) could be beneficial. Conversely, in tumors that seem to exploit KCTD12 for proliferation, disrupting the KCTD12–CDK1 interaction is a novel angle for therapy ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L533%20inhibition%20of,102)). A 2020 study showed that an existing drug (adefovir dipivoxil) unexpectedly could disrupt the KCTD12–CDK1 complex, sensitizing colon cancer cells to a BRAF inhibitor ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20KCTD12%20to%20esophageal%20squamous,2018%3B18%281%29%3A853)). This suggests that **repurposing drugs to modulate KCTD12’s protein interactions** might have therapeutic merit in certain cancers. All of these applications are in early research stages, with ongoing studies to validate KCTD12 as a safe and effective target.

- **Research Tool and Pathway Marker:** KCTD12 is also used in research as a **marker of certain cell states**. For example, in neuroscience, it serves as a marker of mature inhibitory synapses due to its enrichment in neuronal tissue. In cancer biology, changes in KCTD12 are sometimes measured to indicate a shift towards a stem-like state or EMT (epithelial–mesenchymal transition) in tumors ([www.nature.com](https://www.nature.com/articles/srep20460#:~:text=we%20demonstrated%20that%20KCTD12%2C%20potassium,decreased%20level%20of%20KCTD12%20is)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20colorectal%20cancer%20,98)). As a member of the **Cullin3-independent BTB proteins**, KCTD12 is studied to better understand the structural basis of BTB domain specificity. Crystallographic analyses of KCTD12 domains (including PDB structures of KCTD12 H1 in complex with Gβγ) provide a template for designing molecules that can modulate its function ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor)) ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2)).

## Recent Developments and Expert Perspectives (2023–2024)  
Research on KCTD12 is very active, with recent studies expanding our understanding of its roles. In **2023**, a pan-cancer analysis (Scientific Reports, Sept 2023) provided a comprehensive update on KCTD12 in oncology ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=Abnormal%20expression%20of%20the%20potassium,genomic%20heterogeneity%2C%20and%20diagnostic%20specificity)). This analysis reinforced that **abnormal KCTD12 expression is widespread across cancers** and often correlates with clinical outcomes ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=using%20The%20Cancer%20Genome%20Atlas,significantly%20associated%20with%20the%20prognosis)) ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=levels%20decreased%20in%20most%20tumors,KCTD12%20showed%20high)). Specifically, the study found that **KCTD12 downregulation in tumors like colorectal, uterine, and liver cancer is associated with worse survival**, supporting the tumor-suppressor view. It also highlighted KCTD12’s relationship with the tumor immune microenvironment: for instance, in several cancers (cervical, head/neck, pancreatic), higher KCTD12 correlated with greater infiltration of CD8⁺ T cells and fibroblasts, suggesting KCTD12 might influence or reflect immune activation in tumors ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=correlations%20with%20tumor%20stage%20and,PAAD%29%2C%20lung)) ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=tumors%2C%20such%20as%20S200%20and,may%20be%20involved%20in%20tumor)). Such insights are prompting new questions about whether KCTD12 has immunomodulatory functions in cancer or if it’s simply a marker of a less aggressive, more immune-accessible tumor phenotype.

**Authoritative reviews** have also synthesized knowledge on KCTD12. A 2021 review in *Cell Communication and Signaling* noted that *“KCTD12 has been linked to tumorigenesis, in some contexts as a potential oncosuppressor, in other contexts as an oncogene.”* ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin)). This reflects the consensus that KCTD12’s function is context-dependent. The same review emphasizes KCTD12’s origin as a fetal gene and its prominence in neurological function (GABA<sub>B</sub> modulation) alongside its emerging cancer roles ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin)). Experts stress examining the **molecular interactions of KCTD12** to explain these divergent roles. For example, Dr. Enrico De Smaele and colleagues (2021) propose that when KCTD12 is part of a Cullin3 ubiquitin pathway (even if binding is weak, perhaps via hetero-oligomerization with other KCTDs), it might affect protein degradation processes, whereas in neurons it clearly works in a Cullin-independent manner ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94)) ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do)). Understanding these nuances is key to leveraging KCTD12 in medicine.

In the **neuroscience field**, recent structural work has provided *near-atomic detail* of KCTD12. Cryo-EM and crystallography studies by Maestro et al. (2019) elucidated how KCTD12’s H1 domain latches onto Gβγ and how the BTB tetramer connects to GABA<sub>B2</sub> ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2)) ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor)). These structural insights confirm earlier functional data and suggest ways to modulate KCTD12’s effect. For instance, mutants of KCTD12 that disrupt Gβγ binding (e.g. an H1 domain mutant of conserved arginine residues) fail to localize properly or induce desensitization ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor)). Such findings could inform the design of **small molecules that disrupt KCTD12–Gβγ** interactions as a means to tweak GABA<sub>B</sub> signaling. As of 2024, no drugs target KCTD12 specifically, but the concept of **“auxiliary subunit pharmacology”** is gaining traction – i.e., targeting receptor complexes via their accessory subunits.

Another recent development is the exploration of **KCTD12 in psychiatric genetics**. Building on earlier GWAS signals, studies in 2022–2023 have examined KCTD12’s brain expression and regulatory variants. While findings are still preliminary, *KCTD12 is increasingly recognized as a gene of interest in neuropsychiatric conditions* such as schizophrenia, autism, and mood disorders. Its role in modulating inhibitory neurotransmission makes it a plausible contributor to neural circuit dysfunctions underlying these illnesses. 

Finally, the research community is investigating **KCTD12 isoforms and homologs**. There is a splice variant sometimes called KCTD12b (originally identified in certain species), which shares similarity with KCTD12. Studies are determining if KCTD12b in humans has distinct functions or tissue distribution. Additionally, cross-species comparisons (e.g., examining KCTD12 in model organisms like *Drosophila* or *C. elegans*, which have related BTB proteins) are used to infer evolutionarily conserved functions. The fact that KCTD12 is conserved in vertebrates and highly expressed in the brain suggests it performs a fundamental role in GABAergic neurotransmission.

## Conclusion  
**KCTD12** is a multifaceted protein that serves as a key auxiliary factor for GABA<sub>B</sub> receptors in the brain and has context-dependent roles in cell signaling and cancer biology. Its BTB/POZ domain-driven tetramerization and specific protein interactions enable it to modulate receptor trafficking, signal transduction kinetics, and intracellular pathways like ERK and AKT. In neurons, KCTD12 fine-tunes inhibitory synaptic transmission – effectively balancing the strength and duration of GABA<sub>B</sub> signals. Beyond the brain, KCTD12’s influence on pathways that govern cell proliferation and differentiation has made it a subject of interest in oncology, where it can act as either a brake or an accelerator on tumor growth depending on the cellular context. 

Recent research (especially from 2021–2023) has expanded our understanding of KCTD12’s functions, from high-resolution structures explaining its mechanism, to clinical data establishing it as a prognostic biomarker in cancers. **Expert analyses concur that KCTD12 is an important regulatory hub** at the intersection of neurotransmission and cell signaling ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the)). Its precise roles are still being elucidated, but evidence so far positions KCTD12 as an inhibitor of pathological cell behaviors (like unchecked proliferation and metastasis in certain tumors) and as a modulator of neural inhibition with relevance to stress and mood regulation. Moving forward, KCTD12 represents a promising target or marker in both neurological disorders and oncology. Continued studies into how KCTD12’s BTB domain selects its partners, how its expression is regulated (e.g. developmental and tissue-specific cues), and how it can be modulated by drugs or mutations will provide deeper insights. This will not only clarify the fundamental biology of **BTB-domain proteins** but could also lead to novel therapeutic strategies that harness the unique modulatory functions of KCTD12 in human health and disease.

**References:** (Key sources are recent and authoritative)  

- Schwenk et al., *Nature* (2010) – Identified KCTD12/8/16 as auxiliary subunits of native GABA<sub>B</sub> receptors ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=12,View%20Article)).  
- Tureček et al., *J. Neurosci.* (2014) – Described kinetic effects of KCTD12 on GABA<sub>B</sub> currents (fast desensitization).  
- Gilchrist et al., *J. Biol. Chem.* (2013) – Showed KCTD12 enhances GABA<sub>B</sub> surface expression and signaling ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=remains%20associated%20with%20the%20receptor,of%20the%20auxiliary%20subunit%20KCTD12)).  
- Smaldone et al., *PLOS One* (2015) – Demonstrated that KCTD12’s BTB domain does not bind Cullin3, distinguishing cullin-dependent vs independent KCTDs ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do)) ([journals.plos.org](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=heat%20exchanges%20upon%20titration%20of,This)).  
- Maestro et al., *Nature* (2019) – Solved structural basis for KCTD12-mediated GABA<sub>B</sub> signal desensitization ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor)) ([www.nature.com](https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2)).  
- Li et al., *Sci. Rep.* (2016) – Reported KCTD12 suppresses colorectal cancer stemness via ERK pathway; low KCTD12 predicts worse CRC survival ([www.nature.com](https://www.nature.com/articles/srep20460#:~:text=using%20a%20colony%20formation%20assay%2C,this%20report%20reveals%20that%20KCTD12)) ([www.nature.com](https://www.nature.com/articles/srep20460#:~:text=CD44%2C%20CD133%20and%20CD29%2C%20by,target%20for%20patients%20with%20CRC)).  
- Ye et al., *Transl. Cancer Res.* (2021) – Linked low KCTD12 to poor breast cancer outcomes and immune evasion ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of)).  
- Taghehchian et al., *BMC Cancer* (2018) – Noted KCTD12 downregulation in ESCC and tumor-suppressive effects.  
- Zhong et al., *Oncogene* (2017) – Found KCTD12 can promote G2/M transition via CDK1/CDC25B in some cancers ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1)).  
- De Smaele et al., *Cell Commun. Signal.* (2021) – Comprehensive review on KCTD proteins in cancer (summarizes KCTD12’s dual roles) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin)) ([biosignaling.biomedcentral.com](https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin)).  
- Pan-Cancer Analysis by Chi et al., *Sci. Rep.* (2023) – Latest data on KCTD12 expression across cancers and correlation with immune infiltration ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=using%20The%20Cancer%20Genome%20Atlas,significantly%20associated%20with%20the%20prognosis)) ([www.nature.com](https://www.nature.com/articles/s41598-023-41091-8#:~:text=tumors%2C%20such%20as%20S200%20and,may%20be%20involved%20in%20tumor)).  

All the above sources and data points converge on the depiction of KCTD12 as a critical **BTB-domain adaptor protein** with specialized roles in GABA<sub>B</sub> receptor function and significant implications in human diseases ranging from neurological disorders to cancer. The ongoing research continues to refine this understanding, making KCTD12 an exciting subject in functional genomics and molecular medicine. 



## Citations

1. AnnotationURLCitation(end_index=512, start_index=300, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
2. AnnotationURLCitation(end_index=973, start_index=817, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=The%20KCTD%20family%20arose%20from,15')
3. AnnotationURLCitation(end_index=1236, start_index=1074, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=evolutive%20divergence%20and%20share%20a,15')
4. AnnotationURLCitation(end_index=1500, start_index=1308, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L268%20The%20circular,proteins%20assumed%20a%20tetrameric%20organization')
5. AnnotationURLCitation(end_index=1889, start_index=1729, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=a%2C%20Ribbon%20representation%20of%20the,H1%7D%20subunits%20%28green%20and%20cyan')
6. AnnotationURLCitation(end_index=2372, start_index=2189, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=pfetin%2C%20C13orf2%2C%20and%20PFET1%2C%20is,levels%20in%20the%20brain%20and')
7. AnnotationURLCitation(end_index=2538, start_index=2373, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94')
8. AnnotationURLCitation(end_index=2839, start_index=2627, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
9. AnnotationURLCitation(end_index=3143, start_index=2960, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=pfetin%2C%20C13orf2%2C%20and%20PFET1%2C%20is,levels%20in%20the%20brain%20and')
10. AnnotationURLCitation(end_index=4201, start_index=4077, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=12,View%20Article')
11. AnnotationURLCitation(end_index=4494, start_index=4329, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94')
12. AnnotationURLCitation(end_index=4816, start_index=4654, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=proteins%20,pronounced%20desensitization%20of%20the%20K')
13. AnnotationURLCitation(end_index=5132, start_index=5006, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=GABA,thereby%20increases%20the%20magnitude%20of')
14. AnnotationURLCitation(end_index=5363, start_index=5237, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=receptors%20associate%20with%20KCTD12%20while,B')
15. AnnotationURLCitation(end_index=5939, start_index=5775, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=influence%20maturation%20of%20the%20receptor,receptors%20at%20the%20neuronal%20plasma')
16. AnnotationURLCitation(end_index=6595, start_index=6432, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=remains%20associated%20with%20the%20receptor,of%20the%20auxiliary%20subunit%20KCTD12')
17. AnnotationURLCitation(end_index=6983, start_index=6807, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=constitutive%20receptor%20internalization%20and%20thereby,of%20the%20auxiliary%20subunit%20KCTD12')
18. AnnotationURLCitation(end_index=7506, start_index=7343, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=distribution%20to%20axons%20and%20dendrites,association%20with%20KCTD12%20does%20not')
19. AnnotationURLCitation(end_index=7690, start_index=7507, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=pfetin%2C%20C13orf2%2C%20and%20PFET1%2C%20is,levels%20in%20the%20brain%20and')
20. AnnotationURLCitation(end_index=8038, start_index=7876, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=proteins%20,pronounced%20desensitization%20of%20the%20K')
21. AnnotationURLCitation(end_index=8265, start_index=8173, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=G%CE%B1_,stain')
22. AnnotationURLCitation(end_index=8374, start_index=8266, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
23. AnnotationURLCitation(end_index=8667, start_index=8559, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
24. AnnotationURLCitation(end_index=8838, start_index=8668, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
25. AnnotationURLCitation(end_index=9138, start_index=8976, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=proteins%20,pronounced%20desensitization%20of%20the%20K')
26. AnnotationURLCitation(end_index=9389, start_index=9229, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=a%2C%20Ribbon%20representation%20of%20the,H1%7D%20subunits%20%28green%20and%20cyan')
27. AnnotationURLCitation(end_index=9859, start_index=9696, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=distribution%20to%20axons%20and%20dendrites,association%20with%20KCTD12%20does%20not')
28. AnnotationURLCitation(end_index=10944, start_index=10784, title='Genome-wide association analysis reveals KCTD12 and miR-383-binding genes in the background of rumination | Translational Psychiatry', type='url_citation', url='https://www.nature.com/articles/s41398-019-0454-1#:~:text=hit%20emerged%20at%20the%20SNP,transdiagnostic%20nature%20of%20rumination%2C%20and')
29. AnnotationURLCitation(end_index=11202, start_index=11044, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=of%20KCTD12%3A%20insights%20into%20interaction,26%2C%20488%E2%80%93495%20%282013')
30. AnnotationURLCitation(end_index=11628, start_index=11434, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=to%20investigate%20behavioral%20responses%20to,suppressing%20the%20excess%20expression%20of')
31. AnnotationURLCitation(end_index=11819, start_index=11629, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=increased%20the%20expression%20of%20Kctd12,suppressing%20the%20excess%20expression%20of')
32. AnnotationURLCitation(end_index=12278, start_index=12091, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=The%20effects%20of%20Kctd12%2C%20an,mood%20disorders%20like%20depression%20treatment')
33. AnnotationURLCitation(end_index=12929, start_index=12737, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L268%20The%20circular,proteins%20assumed%20a%20tetrameric%20organization')
34. AnnotationURLCitation(end_index=13312, start_index=13142, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
35. AnnotationURLCitation(end_index=13621, start_index=13462, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=a%2C%20KCTD16_,down%20with%20glutathione%E2%80%93sepharose%20beads.%20Glutathione')
36. AnnotationURLCitation(end_index=14283, start_index=14129, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do')
37. AnnotationURLCitation(end_index=14436, start_index=14284, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=heat%20exchanges%20upon%20titration%20of,This')
38. AnnotationURLCitation(end_index=14811, start_index=14657, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do')
39. AnnotationURLCitation(end_index=14936, start_index=14812, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=https%3A%2F%2Fdoi')
40. AnnotationURLCitation(end_index=15924, start_index=15805, title='KCTD12 modulation of GABA(B) receptor function - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5508304/#:~:text=Introduction%20GABA_,GIRK%2C%20also')
41. AnnotationURLCitation(end_index=16346, start_index=16133, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the')
42. AnnotationURLCitation(end_index=16767, start_index=16554, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the')
43. AnnotationURLCitation(end_index=17125, start_index=16912, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the')
44. AnnotationURLCitation(end_index=17894, start_index=17694, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L518%20KCTD12%20displays,Consistently%2C%20ectopic%20expression%20of')
45. AnnotationURLCitation(end_index=18102, start_index=17895, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
46. AnnotationURLCitation(end_index=18624, start_index=18429, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
47. AnnotationURLCitation(end_index=18960, start_index=18765, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
48. AnnotationURLCitation(end_index=19345, start_index=19149, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=levels%20have%20been%20correlated%20with,a%20complex%20that%20supports%20CDK1')
49. AnnotationURLCitation(end_index=21201, start_index=20989, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
50. AnnotationURLCitation(end_index=21385, start_index=21202, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097')
51. AnnotationURLCitation(end_index=21697, start_index=21514, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097')
52. AnnotationURLCitation(end_index=22140, start_index=21967, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=solitary%20fibrous%20tumor%20%20,These%20findings%20suggest%20that')
53. AnnotationURLCitation(end_index=22456, start_index=22299, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=recurrence,diagnosis%20and%20prognosis%20of%20GIST')
54. AnnotationURLCitation(end_index=22739, start_index=22563, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=after%20accounting%20for%20Ki,diagnosis%20and%20prognosis%20of%20GIST')
55. AnnotationURLCitation(end_index=23091, start_index=22908, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097')
56. AnnotationURLCitation(end_index=23571, start_index=23425, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=CD44%2C%20CD133%20and%20CD29%2C%20by,this%20report%20reveals%20that%20KCTD12')
57. AnnotationURLCitation(end_index=23889, start_index=23746, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=CD44%2C%20CD133%20and%20CD29%2C%20by,target%20for%20patients%20with%20CRC')
58. AnnotationURLCitation(end_index=24300, start_index=24145, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=we%20demonstrated%20that%20KCTD12%2C%20potassium,decreased%20level%20of%20KCTD12%20is')
59. AnnotationURLCitation(end_index=24681, start_index=24530, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=using%20a%20colony%20formation%20assay%2C,this%20report%20reveals%20that%20KCTD12')
60. AnnotationURLCitation(end_index=25060, start_index=24911, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20colorectal%20cancer%20,98')
61. AnnotationURLCitation(end_index=25210, start_index=25061, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20colorectal%20cancer%20,98')
62. AnnotationURLCitation(end_index=25804, start_index=25604, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L518%20KCTD12%20displays,Consistently%2C%20ectopic%20expression%20of')
63. AnnotationURLCitation(end_index=26126, start_index=25926, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L518%20KCTD12%20displays,Consistently%2C%20ectopic%20expression%20of')
64. AnnotationURLCitation(end_index=26489, start_index=26282, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
65. AnnotationURLCitation(end_index=26881, start_index=26674, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
66. AnnotationURLCitation(end_index=27213, start_index=27006, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
67. AnnotationURLCitation(end_index=27691, start_index=27547, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8798602/#:~:text=Ribonucleic%20acid,and%20the%20Gene%20Expression%20Profiling')
68. AnnotationURLCitation(end_index=27786, start_index=27692, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8798602/#:~:text=Background')
69. AnnotationURLCitation(end_index=28060, start_index=27916, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8798602/#:~:text=Ribonucleic%20acid,and%20the%20Gene%20Expression%20Profiling')
70. AnnotationURLCitation(end_index=28449, start_index=28315, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - Wang - Translational Cancer Research', type='url_citation', url='https://tcr.amegroups.org/article/view/48228/html#:~:text=,Biomarker%20of%20Gastrointestinal%20Stromal%20Tumors')
71. AnnotationURLCitation(end_index=28746, start_index=28612, title='KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration - Wang - Translational Cancer Research', type='url_citation', url='https://tcr.amegroups.org/article/view/48228/html#:~:text=,Biomarker%20of%20Gastrointestinal%20Stromal%20Tumors')
72. AnnotationURLCitation(end_index=29044, start_index=28889, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L522%20KCTD12%20in,ESCC')
73. AnnotationURLCitation(end_index=29323, start_index=29168, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L522%20KCTD12%20in,ESCC')
74. AnnotationURLCitation(end_index=29858, start_index=29696, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20in%20human%20uveal%20melanoma,ESCC')
75. AnnotationURLCitation(end_index=30120, start_index=29958, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20in%20human%20uveal%20melanoma,ESCC')
76. AnnotationURLCitation(end_index=30709, start_index=30514, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
77. AnnotationURLCitation(end_index=30906, start_index=30710, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=levels%20have%20been%20correlated%20with,a%20complex%20that%20supports%20CDK1')
78. AnnotationURLCitation(end_index=31381, start_index=31186, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
79. AnnotationURLCitation(end_index=31771, start_index=31576, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
80. AnnotationURLCitation(end_index=32100, start_index=31904, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=levels%20have%20been%20correlated%20with,a%20complex%20that%20supports%20CDK1')
81. AnnotationURLCitation(end_index=32884, start_index=32688, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin')
82. AnnotationURLCitation(end_index=33097, start_index=32885, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
83. AnnotationURLCitation(end_index=33709, start_index=33526, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20gastrointestinal%20stromal%20tumors%20%28GIST%29,96%2C%2097')
84. AnnotationURLCitation(end_index=34051, start_index=33878, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=solitary%20fibrous%20tumor%20%20,These%20findings%20suggest%20that')
85. AnnotationURLCitation(end_index=34325, start_index=34168, title='Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/abs/pii/S0046817712003814#:~:text=recurrence,diagnosis%20and%20prognosis%20of%20GIST')
86. AnnotationURLCitation(end_index=34641, start_index=34458, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=Abnormal%20expression%20of%20the%20potassium,genomic%20heterogeneity%2C%20and%20diagnostic%20specificity')
87. AnnotationURLCitation(end_index=34783, start_index=34642, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=levels%20decreased%20in%20most%20tumors,KCTD12%20showed%20high')
88. AnnotationURLCitation(end_index=35106, start_index=34951, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=using%20The%20Cancer%20Genome%20Atlas,of%20KCTD12%20decreased%20in%20several')
89. AnnotationURLCitation(end_index=35496, start_index=35355, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=levels%20decreased%20in%20most%20tumors,KCTD12%20showed%20high')
90. AnnotationURLCitation(end_index=35832, start_index=35673, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=tumors%2C%20such%20as%20S200%20and,stemness%2C%20tumor%20burden%2C%20and%20other')
91. AnnotationURLCitation(end_index=36556, start_index=36366, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=increased%20the%20expression%20of%20Kctd12,suppressing%20the%20excess%20expression%20of')
92. AnnotationURLCitation(end_index=36753, start_index=36557, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=acute%20stress%20and%20increased%20vulnerability,suppressing%20the%20excess%20expression%20of')
93. AnnotationURLCitation(end_index=37317, start_index=37123, title='The effects of Kctd12, an auxiliary subunit of GABAB receptor in dentate gyrus on behavioral response to chronic social defeat stress in mice - ScienceDirect', type='url_citation', url='https://www.sciencedirect.com/science/article/pii/S1043661820316637#:~:text=to%20investigate%20behavioral%20responses%20to,suppressing%20the%20excess%20expression%20of')
94. AnnotationURLCitation(end_index=37923, start_index=37765, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L533%20inhibition%20of,102')
95. AnnotationURLCitation(end_index=38273, start_index=38091, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=of%20KCTD12%20to%20esophageal%20squamous,2018%3B18%281%29%3A853')
96. AnnotationURLCitation(end_index=39086, start_index=38931, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=we%20demonstrated%20that%20KCTD12%2C%20potassium,decreased%20level%20of%20KCTD12%20is')
97. AnnotationURLCitation(end_index=39236, start_index=39087, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20colorectal%20cancer%20,98')
98. AnnotationURLCitation(end_index=39668, start_index=39560, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
99. AnnotationURLCitation(end_index=39839, start_index=39669, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
100. AnnotationURLCitation(end_index=40304, start_index=40121, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=Abnormal%20expression%20of%20the%20potassium,genomic%20heterogeneity%2C%20and%20diagnostic%20specificity')
101. AnnotationURLCitation(end_index=40608, start_index=40440, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=using%20The%20Cancer%20Genome%20Atlas,significantly%20associated%20with%20the%20prognosis')
102. AnnotationURLCitation(end_index=40750, start_index=40609, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=levels%20decreased%20in%20most%20tumors,KCTD12%20showed%20high')
103. AnnotationURLCitation(end_index=41384, start_index=41246, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=correlations%20with%20tumor%20stage%20and,PAAD%29%2C%20lung')
104. AnnotationURLCitation(end_index=41531, start_index=41385, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=tumors%2C%20such%20as%20S200%20and,may%20be%20involved%20in%20tumor')
105. AnnotationURLCitation(end_index=42182, start_index=41986, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin')
106. AnnotationURLCitation(end_index=42591, start_index=42426, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94')
107. AnnotationURLCitation(end_index=42804, start_index=42592, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
108. AnnotationURLCitation(end_index=43385, start_index=43220, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%2C%20KCTD8%20and%20KCTD16%20proteins,94')
109. AnnotationURLCitation(end_index=43540, start_index=43386, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do')
110. AnnotationURLCitation(end_index=44048, start_index=43878, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
111. AnnotationURLCitation(end_index=44157, start_index=44049, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
112. AnnotationURLCitation(end_index=44538, start_index=44430, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
113. AnnotationURLCitation(end_index=47424, start_index=47228, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin')
114. AnnotationURLCitation(end_index=47638, start_index=47425, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=G%CE%B2%CE%B3%20activates%20PI3K%20that%20phosphorylates,as%20positive%20regulators%20of%20the')
115. AnnotationURLCitation(end_index=48775, start_index=48651, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=12,View%20Article')
116. AnnotationURLCitation(end_index=49194, start_index=49031, title='Up-regulation of GABA(B) receptor signaling by constitutive assembly with the K+ channel tetramerization domain-containing protein 12 (KCTD12) - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/23843457/#:~:text=remains%20associated%20with%20the%20receptor,of%20the%20auxiliary%20subunit%20KCTD12')
117. AnnotationURLCitation(end_index=49505, start_index=49351, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=known%20to%20be%20involved%20either,BTB%7D%20do')
118. AnnotationURLCitation(end_index=49658, start_index=49506, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=heat%20exchanges%20upon%20titration%20of,This')
119. AnnotationURLCitation(end_index=49890, start_index=49782, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=and%20G%CE%B2_,B%7D%20receptor')
120. AnnotationURLCitation(end_index=50061, start_index=49891, title='Structural basis for KCTD-mediated rapid desensitization of GABAB signalling | Nature', type='url_citation', url='https://www.nature.com/articles/s41586-019-0990-0#:~:text=microscopy%20reconstruction%20of%20full,terminal%20domain%20and%20G%CE%B2_%7B1%7D%CE%B3_%7B2')
121. AnnotationURLCitation(end_index=50360, start_index=50209, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=using%20a%20colony%20formation%20assay%2C,this%20report%20reveals%20that%20KCTD12')
122. AnnotationURLCitation(end_index=50504, start_index=50361, title='KCTD12 Regulates Colorectal Cancer Cell Stemness through the ERK Pathway | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/srep20460#:~:text=CD44%2C%20CD133%20and%20CD29%2C%20by,target%20for%20patients%20with%20CRC')
123. AnnotationURLCitation(end_index=50827, start_index=50620, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=KCTD12%20displays%20a%20reduced%20expression,Consistently%2C%20ectopic%20expression%20of')
124. AnnotationURLCitation(end_index=51248, start_index=51053, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=In%20other%20contexts%2C%20KCTD12%20may,a%20complex%20that%20supports%20CDK1')
125. AnnotationURLCitation(end_index=51581, start_index=51385, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=match%20at%20L506%20contexts%20as,In%20particular%2C%20a%20decreased%20pfetin')
126. AnnotationURLCitation(end_index=51794, start_index=51582, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8#:~:text=contexts%20as%20a%20potential%20oncosuppressor%2C,In%20particular%2C%20a%20decreased%20pfetin')
127. AnnotationURLCitation(end_index=52113, start_index=51945, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=using%20The%20Cancer%20Genome%20Atlas,significantly%20associated%20with%20the%20prognosis')
128. AnnotationURLCitation(end_index=52260, start_index=52114, title='A pan-cancer analysis of potassium channel tetramerization domain containing 12 in human cancer | Scientific Reports', type='url_citation', url='https://www.nature.com/articles/s41598-023-41091-8#:~:text=tumors%2C%20such%20as%20S200%20and,may%20be%20involved%20in%20tumor')